Jiangsu Hengrui Medicine Co., Ltd.

This study is testing a new oral drug, HRS-1167, given alongside two standard prostate cancer medications (abiraterone and prednisone) in men whose cancer has spread. The main goals are to find a safe and effective dose and to see how well the combination works to control the can…

This study is testing whether adding SHR2554 tablets to other cancer treatments is safe and effective for people with advanced non-small cell lung cancer. Researchers will enroll 200 adults to see if this combination helps shrink tumors and control the disease. The trial focuses …

This large, late-stage trial is comparing a new three-drug combination to the current standard treatment for advanced pancreatic cancer that has spread. It aims to see if the new approach helps patients live longer or better control their cancer. The study will enroll 662 adults …

This study is testing whether a new oral tablet (SHR0302) alone or combined with a matching gel can help restore skin color in adults with non-segmental vitiligo. Researchers will measure changes in the size and appearance of white patches on the face and body over 24 weeks. The …

This study is testing an experimental drug called HRS-4508 for people with advanced non-small cell lung cancer that has spread or can't be removed by surgery. The trial will enroll 120 patients whose cancer has continued to grow despite standard treatments. Researchers want to se…

This is the first study in people to test a new drug called HRS-7172. It aims to find a safe dose and see how the body processes the drug in 120 adults with advanced solid tumors that have specific genetic changes (RAS mutations or amplifications). The main goal is to check for s…

This study is testing if a drug called Herombopag can safely increase platelet counts in people with chronic liver disease who need elective surgery. Low platelets increase bleeding risk during procedures. The goal is to see if the drug can raise counts enough to avoid needing pl…

This study is testing a new drug called FH-006 for people with advanced solid tumors that have grown despite standard treatments. The main goals are to find a safe and effective dose and to see how well the drug works at controlling the cancer. It is for adults whose cancer has r…

This early-stage trial is testing a new radioactive drug called HRS-6768 in patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see how the drug moves through and affects the body. Re…

This early-stage study is testing an experimental drug called SHR-A1904 in people with advanced solid tumors, specifically gastric, pancreatic, and other cancers that have stopped responding to standard treatments. The main goals are to find the safest and most effective dose, ch…

This study is testing whether a new oral drug called HRS-5041, when given alongside other standard prostate cancer treatments, is safe and effective for men with advanced disease. It will involve about 100 male participants to find the best dose and see how well it controls cance…

This early-stage trial is testing whether a new drug called HRS-4642, when combined with other cancer treatments, is safe and effective for people with advanced solid tumors that have a specific genetic change (KRAS G12D mutation). The study aims to find the best dose and see if …

This study is testing whether adding a new oral drug called SHR2554 to other cancer treatments is safe and effective for people with advanced stomach cancer that has spread or cannot be removed by surgery. It will involve about 351 adults with this condition. The main goals are t…

This study is testing whether an experimental drug called SHR-A1811 works better than current standard treatments for people with advanced lung cancer that has specific HER2 mutations. Researchers will enroll 300 adults who haven't had previous treatment for their advanced cancer…

This study is testing a new drug called HRS-6209, given in combination with other treatments, for women with breast cancer. The main goals are to find a safe dose and see if the drug combination shows early signs of helping to control the cancer. The study will enroll about 80 wo…

This study is testing a new drug called FH-006 when given alongside other standard lung cancer treatments. It aims to find the safest and most effective dose and see how well it helps shrink tumors in people with advanced lung cancer that can't be cured with surgery or radiation.…

This study is for people with advanced stomach or gastroesophageal junction cancer that has continued to grow after their first round of chemotherapy. It aims to see if a new combination of two drugs (camrelizumab and apatinib) can help people live longer than the current standar…

This study is testing an experimental drug called SHR-A1811 for women with advanced cervical cancer that has returned or spread and no longer responds to standard treatments. The trial will enroll 60 participants to see if the drug can shrink tumors and control the cancer. Resear…

This study aims to see if a new drug called SHR2554 works better than an existing drug, chidamide, for adults with a type of blood cancer called PTCL that has come back or hasn't responded to prior treatment. It's a large, late-stage trial where neither the doctors nor the patien…

This is the first study in people to test a new drug called HRS-6093, which is designed to target a specific genetic change (KRAS G12D mutation) found in some advanced solid tumors. The main goal is to find a safe dose and understand how the drug moves through the body in about 1…

This is the first study in people testing a new drug called HRS-2329 for advanced solid tumors that have specific genetic changes called RAS mutations or amplifications. The main goal is to find a safe dose and understand how the drug moves through the body. It will enroll about …

This study is testing whether a new drug called HRS-4357 works better than current standard medications for men with advanced prostate cancer that has spread and stopped responding to hormone therapy. About 370 participants will be randomly assigned to receive either the new drug…

This study is testing whether a new drug called SHR-A1811 works better than the current standard treatment for shrinking HER2-positive breast tumors before surgery. About 740 women with early or locally advanced breast cancer will receive either the new drug or standard chemother…

This study is testing whether adding one of two new oral drugs (HS-20093 or SHR2554) to standard hormone therapy helps men with advanced prostate cancer that has spread. It will enroll 218 men to see if these combinations are safe and can better control the cancer by lowering PSA…

This study compares two medications, rezvilutamide and enzalutamide, for men with prostate cancer that has spread but still responds to hormone-blocking therapy. Both drugs will be given alongside standard hormone treatment to see which one better controls cancer growth and cause…

This study is testing whether a new drug called HRS-4508, when combined with other cancer therapies, can help control advanced lung cancer. It's for people whose cancer has continued to grow despite standard treatments. Researchers will measure how well the combination works and …

This study is testing a new muscle-relaxing drug called HRS-9190 against the commonly used drug rocuronium. It aims to see if HRS-9190 works as well or better at keeping patients' muscles relaxed and still during elective surgery under general anesthesia. The study will measure h…

This study is testing a new, long-lasting numbing medicine injected near the spine to control pain after minimally invasive lung surgery. Researchers want to see if this special, slow-release formula provides better and longer pain relief than standard options. The trial will inv…

This study is testing a special, long-lasting numbing injection given during surgery to see if it safely controls pain for up to 3 days afterward in children aged 6-17. The main goal is to check for side effects related to the heart or nervous system. Researchers also want to see…

This study is testing a new injection called Tegileridine Fumarate to see if it can safely and effectively manage pain and sedation for 2-3 days in ICU patients who need help breathing from a machine. It will compare the new drug to an existing standard treatment. The goal is to …

This study is testing a sedative medicine called remimazolam to see if it is safe and works well for keeping children and teenagers asleep and comfortable during surgery. It will involve 240 young patients who are having planned operations. Researchers will measure how well the s…

This is an early-stage study to understand how a new injection called SHR-3167 behaves in the body of people with type 2 diabetes. It will measure the drug's levels in the blood over time and check for side effects, including low blood sugar. The goal is to gather basic safety an…

This is an early-stage study to check if a new injectable drug called HRS-2183 is safe and how it moves through the body. It involves 42 healthy Chinese adults who will receive single or multiple doses. The main goal is to monitor for side effects and measure how the drug is abso…